Skip to main content

Table 7 Comparison of serum level of cytokines between patients with and without recurrent wheezing episodes

From: Risk factors for recurrent wheezing after bronchiolitis in infants: 2-year follow up in China

cytokines

RW(−), n = 63

RW(+), n = 18

statistics

P

IL-2

4.43 (1.25–17.86)

3.87 (1.17–6.78)

−0.357

0.721

TNF-α

1.18 (0.00–4.57)

0.78 (0.00–2.97)

−0.410

0.159

IL-4

25.02 (6.86–47.18)

20.81 (7.83–39.7)

−1.609

0.108

IL-5

7.52 (2.41–16.06)

6.50 (1.78–11.55)

−1.021

0.307

IL-13

3.01 (0.75–6.42)

2.52 (1.22–4.20)

− 1.392

0.164

MIP-1α

14.25 (7.68–32.24)

12.98 (7.61–18.85)

−0.825

0.409

IL-25

60.11 (19.53–124.22)

48.46 (15.99–108.74)

−1.833

0.067

IL-33

30.84 (12.69–77.18)

27.93 (7.75–50.12)

−0.643

0.520

TSLP

10.34 (3.98–18.42)

9.01 (3.27–14.16)

−1.259

0.208

MMP-9

1575.09 (23.71–9040.32)

1436.08 (116.00–6946.29)

−0.825

0.409

TIMP-1

379.44 (207.97–881.72)

427.50 (256.60–797.00)

−1.343

0.179

  1. note: RW(+), patients with recurrent wheezing episodes; RW (−), patients without recurrent wheezing episodes
  2. Data are expressed as median (minimum-maximum), unless otherwise stated